These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30762614)

  • 1. Blood pressure targets and kidney and cardiovascular disease: same data but discordant guidelines.
    Roehm B; Weiner DE
    Curr Opin Nephrol Hypertens; 2019 May; 28(3):245-250. PubMed ID: 30762614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In the Wake of Systolic Blood Pressure Intervention Trial: New Targets for Improving Hypertension Management in Chronic Kidney Disease?
    Tyson CC; Coffman TM
    Nephron; 2017; 135(4):287-290. PubMed ID: 28161697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Hypertension: Which Goal for Which Patient?
    Jarraya F
    Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension in chronic kidney disease after the Systolic Blood Pressure Intervention Trial: targets, treatment and current uncertainties.
    Kovesdy CP
    Nephrol Dial Transplant; 2017 Apr; 32(suppl_2):ii219-ii223. PubMed ID: 28201651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality Outcomes With Intensive Blood Pressure Targets in Chronic Kidney Disease Patients.
    Aggarwal R; Petrie B; Bala W; Chiu N
    Hypertension; 2019 Jun; 73(6):1275-1282. PubMed ID: 31067189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Pressure Targets in CKD: Lessons Learned from SPRINT and Previous Observational Studies.
    Gosmanova EO; Kovesdy CP
    Curr Cardiol Rep; 2016 Sep; 18(9):88. PubMed ID: 27448402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the ideal blood pressure goal for patients with stage III or higher chronic kidney disease?
    Khouri Y; Steigerwalt SP; Alsamara M; McCullough PA
    Curr Cardiol Rep; 2011 Dec; 13(6):492-501. PubMed ID: 21887524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysis.
    Malhotra R; Nguyen HA; Benavente O; Mete M; Howard BV; Mant J; Odden MC; Peralta CA; Cheung AK; Nadkarni GN; Coleman RL; Holman RR; Zanchetti A; Peters R; Beckett N; Staessen JA; Ix JH
    JAMA Intern Med; 2017 Oct; 177(10):1498-1505. PubMed ID: 28873137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care.
    Fraser SD; Roderick PJ; McIntyre NJ; Harris S; McIntyre CW; Fluck RJ; Taal MW
    BMC Fam Pract; 2013 Jun; 14():88. PubMed ID: 23800117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood Pressure Goals in Patients with CKD: A Review of Evidence and Guidelines.
    Chang AR; Lóser M; Malhotra R; Appel LJ
    Clin J Am Soc Nephrol; 2019 Jan; 14(1):161-169. PubMed ID: 30455322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the KDIGO Systolic Blood Pressure Target <120 mm Hg for Chronic Kidney Disease Appropriate in Routine Clinical Practice?
    Dasgupta I; Zoccali C
    Hypertension; 2022 Jan; 79(1):4-11. PubMed ID: 34784720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPRINT and the Kidney: What Have We Learned?
    Wells R; Rahman M
    Curr Hypertens Rep; 2018 Sep; 20(11):95. PubMed ID: 30218213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension control and antihypertensive therapy in patients with chronic kidney disease.
    Unni S; White K; Goodman M; Ye X; Mavros P; Bash LD; Brixner D
    Am J Hypertens; 2015 Jun; 28(6):814-22. PubMed ID: 25421796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive blood pressure lowering in chronic kidney disease: the time has come.
    Ruzicka M; Hiremath S
    Curr Opin Nephrol Hypertens; 2017 May; 26(3):197-204. PubMed ID: 28198732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What Is Wrong with the Blood Pressure Target Recommendation of KDIGO 2021 for Hypertension in Chronic Kidney Disease?
    Jamale T; Kulkarni M; Keskar V
    Nephron; 2023; 147(10):616-620. PubMed ID: 37231907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How early should blood pressure control be achieved for optimal cardiovascular outcomes?
    Weir MR; Zappe D; Orloski LA; Sowers JR
    J Hum Hypertens; 2011 Apr; 25(4):211-7. PubMed ID: 20596060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Hypertension in Chronic Kidney Disease.
    Pugh D; Gallacher PJ; Dhaun N
    Drugs; 2019 Mar; 79(4):365-379. PubMed ID: 30758803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial).
    Patel KK; Arnold SV; Chan PS; Tang Y; Pokharel Y; Jones PG; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?
    Bhatt H; Ghazi L; Calhoun D; Oparil S
    Curr Cardiol Rep; 2016 Oct; 18(10):98. PubMed ID: 27566331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension and kidney disease: what do the data really show?
    Cohen DL; Townsend RR
    Curr Hypertens Rep; 2012 Oct; 14(5):462-7. PubMed ID: 22814743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.